Weightwatchers and bariatric surgery had limited effects on the obese brain, but GLP-1s like Ozempic may mean new hope in ...

Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, ...

Novo Nordisk A/S’s surprise decision to replace Chief Executive Officer Lars Fruergaard Jorgensen has triggered a race to ...

Novo Nordisk said on Friday its CEO Lars Fruergaard Jorgensen will step down following a plunge in the company's share price ...

Wegovy-maker Novo Nordisk said on Friday its CEO Lars Fruergaard Jorgensen will step down over concerns the company is losing ...

Obesity has emerged as one of the most urgent and under-recognised health crises in India, with experts warning that it now functions as a silent tsunami sweeping through the population. A study ...

Two in three adults over the age of 25 could be obese or overweight by 2050, experts have warned. Access to healthy and ...

While the US leads in early-phase obesity trials and investment, the country also faces challenges in disease burden, trial ...

Estrogen generated in the brain may play a role in regulating appetite, potentially opening new avenues for treating obesity.

If child with a high BMI reaches a healthy weight by the age of six, they are no longer at risk of becoming obese later in ...

Novo Nordisk CEO's ouster signals stiff competition in the obesity market, getting dominated by Eli Lilly, with Roche, ...

Research on weight loss drugs like Ozempic shows varied results for mental health impacts, with some patients experiencing mood and personality changes.